Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $44.6 million.

  • Harvard Bioscience's Shares Outstanding rose 220.79% to $44.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 220.79%. This contributed to the annual value of $44.1 million for FY2024, which is 156.47% up from last year.
  • Latest data reveals that Harvard Bioscience reported Shares Outstanding of $44.6 million as of Q3 2025, which was up 220.79% from $44.5 million recorded in Q2 2025.
  • Harvard Bioscience's Shares Outstanding's 5-year high stood at $47.7 million during Q1 2021, with a 5-year trough of $40.5 million in Q2 2021.
  • Its 5-year average for Shares Outstanding is $42.9 million, with a median of $42.7 million in 2023.
  • As far as peak fluctuations go, Harvard Bioscience's Shares Outstanding skyrocketed by 341.49% in 2021, and later plummeted by 1353.36% in 2022.
  • Harvard Bioscience's Shares Outstanding (Quarter) stood at $41.1 million in 2021, then grew by 2.28% to $42.1 million in 2022, then rose by 3.12% to $43.4 million in 2023, then increased by 1.56% to $44.1 million in 2024, then increased by 1.15% to $44.6 million in 2025.
  • Its last three reported values are $44.6 million in Q3 2025, $44.5 million for Q2 2025, and $44.2 million during Q1 2025.